iShares MSCI Hong Kong ETF vs Teladoc Health Inc — how do they compare? iShares MSCI Hong Kong ETF trades at $22.06 (market cap $1.16B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: iShares MSCI Hong Kong ETF and Teladoc Health Inc are close in size by market cap, and iShares MSCI Hong Kong ETF is trading nearer its 52-week high, Teladoc Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Hong Kong ETF for 61 Days and Teladoc Health Inc for 39 Days on average.
| EWH | TDOC | |
|---|---|---|
Market Cap | $1.16B | $1.01B |
Volume | 3,176,523 | 4,668,477 |
Sector | Broad Market / Factor | Health |
52-Week High | $24.55 | $9.72 |
52-Week Low | $20.66 | $4.47 |
Typical Hold Time | 61 Days | 39 Days |
Enterprise Value | — | $1.27B |
Signals from Pluang's Aura AI — not financial advice
EWH, the iShares MSCI Hong Kong ETF, trades at $21.72 with a slight 0.65% daily gain amid a predominantly bearish technical backdrop. The ETF's underlying index, the Hang Seng, has faced significant pressure, dropping over 11% from yearly highs due to Federal Reserve policy concerns and US-Iran geopolitical tensions. Technical indicators show bearish moving averages but neutral oscillators, with RSI levels suggesting potential oversold conditions. Recent institutional activity includes Empowered Funds reducing its position by 70.2% in August 2026.
The outlook remains challenged by Hong Kong's market volatility and external pressures, though current levels may attract contrarian interest given the substantial decline from peaks. Key risks include ongoing geopolitical friction, Federal Reserve policy impacts, and China's economic struggles. Upside potential depends on stabilization in Chinese technology stocks and resolution of international tensions.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →